≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Abscess of lung

DOID EFO Endpoint Browser PheWeb

J10_ABSCLUNGPNEUMO

Lung Abscess: Solitary or multiple collections of PUS within the lung parenchyma as a result of infection by bacteria, protozoa, or other agents.

Suggest a new description

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — J85.1, J85.2
  • Hospital discharge: ICD-9 — 5130
  • Hospital discharge: ICD-8 — 51399
  • Cause of death: ICD-10 — J85.1, J85.2
  • Cause of death: ICD-9 — 5130
  • Cause of death: ICD-8 — 51399

2 out of 7 registries used, show all original rules.

532

4. Check minimum number of events

None

532

5. Include endpoints

None

532

6. Filter based on genotype QC (FinnGen only)

532

Control definitions (FinnGen only)

Control exclude
J10_NECROTIC

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 5076 1557 3417
Only index persons 3512 1180 2332
Unadjusted period prevalence (%)
Whole population 0.08 0.04 0.10
Only index persons 0.07 0.04 0.09
Median age at first event (years)
Whole population 60.33 62.79 59.15
Only index persons 58.66 60.67 57.65

-FinnGen-

Key figures

All Female Male
Number of individuals 532 158 374
Unadjusted period prevalence (%) 0.13 0.05 0.16
Median age at first event (years) 60.59 57.66 61.82

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
472
Matched controls
4718
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
J85.1
ICD-10 Finland
Abscess of lung with pneumonia
+∞
280.0
240
*
J85.2
ICD-10 Finland
Abscess of lung without pneumonia
+∞
237.1
207
*
J18.9
ICD-10 Finland
Pneumonia, unspecified
8.4
97.4
299
802
J86.9
ICD-10 Finland
Pyothorax without fistula
+∞
85.0
79
*
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
16.1
81.9
140
120
UGC12
NOMESCO Finland
Flexible bronchoscopy
10.5
70.8
152
205
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
7.5
56.7
151
278
J01MA14
ATC
moxifloxacin; systemic
8.0
55.4
139
233
J01FF01
ATC
clindamycin; systemic
4.6
49.2
232
820
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
6.7
46.2
132
260
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
4.5
35.6
151
451
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.4
34.8
281
1429
GD1AD
NOMESCO Finland
Thorax CT examination
9.2
34.4
75
95
J01MA12
ATC
levofloxacin; systemic
4.0
33.4
166
569
51399
ICD-8 Finland
Abscess of lung
+∞
28.4
27
*
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
5.1
27.4
94
220
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
13.3
26.1
46
38
JN4BD
NOMESCO Finland
Extensive body CT
4.4
24.4
97
262
5130A
ICD-9 Finland
Abscess of lung and mediastinum, Abscess of lung
+∞
24.2
23
*
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
3.8
22.4
107
340
TGC00
NOMESCO Finland
Bronchial lavation
9.0
20.7
44
53
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
10.0
19.0
38
41
Z2446
NOMESCO Finland
Social worker
5.0
18.5
62
139
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
3.1
18.1
115
446
ZXD05
NOMESCO Finland
Urgent procedure
2.5
17.9
183
949
R03BB04
ATC
tiotropium bromide; inhalant
3.5
17.9
93
313
GAA10
NOMESCO Finland
Intercostal insertion of pleural drainage tube
8.9
17.8
38
46
GD5BD
NOMESCO Finland
Thorax and upper abdomen combined extensive CT examination of
8.8
16.8
36
44
N02AA05
ATC
oxycodone; systemic
3.0
16.8
108
421
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
6.4
16.5
44
75
J86.00
ICD-10 Finland
Empyema with broncho-pleural fistula
+∞
14.7
14
*
GDC00
NOMESCO Finland
Lobectomy of lung
17.7
14.4
22
13
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
14.0
14.4
24
18
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.0
14.1
87
327
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
3.9
14.1
59
165
EBA15
NOMESCO Finland
Extraction of large number of teeth
5.7
13.8
40
76
TPH04
NOMESCO Finland
Cathetrisation of vein
2.5
13.7
124
587
GAC46
NOMESCO Finland
Partial decortication of pleura
77.4
13.7
15
*
B44.1
ICD-10 Finland
Other pulmonary aspergillosis
+∞
13.6
13
*
H02AB06
ATC
prednisolone; systemic
2.1
13.5
239
1544
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
4.3
13.4
51
130
Z3226
NOMESCO Finland
Physiotherapist
2.6
13.4
112
505
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
6.5
13.1
34
56
GA4AT
NOMESCO Finland
Cathetrisation of pleural cavity with ultrasound guidance
17.3
13.1
20
12
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
2.5
13.1
116
543
WX302
NOMESCO Finland
Thoracal epidural anesthesy
5.0
13.0
42
91
R4110
NOMESCO Finland
Physiotherapy
2.3
12.7
145
768
130
Kela drug reimbursment
Malignant tumour
3.3
12.3
64
213
WX892
NOMESCO Finland
Monitored bed care
3.5
12.2
59
186
R03AK06
ATC
salmeterol and fluticasone; inhalant
2.7
12.2
88
365
WX408
NOMESCO Finland
General anesthesy, balanced
2.2
11.9
148
811
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.9
11.9
78
303
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.5
11.7
106
498
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
4.5
11.7
41
97
J45.9
ICD-10 Finland
Asthma, unspecified
2.6
11.7
96
429
J02AC03
ATC
voriconazole; systemic
122.9
11.5
12
*
N03AX16
ATC
pregabalin; oral
2.3
11.3
122
625
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
3.5
11.1
52
160
ZXE20
NOMESCO Finland
More than three and less than five hours
2.6
11.0
89
392
N05AH04
ATC
quetiapine; oral
2.5
11.0
92
414
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
4.0
10.9
44
119
R50.9
ICD-10 Finland
Fever, unspecified
2.6
10.7
82
351
ZXE00
NOMESCO Finland
One hour or less
2.0
10.5
186
1169
A03FA01
ATC
metoclopramide; systemic, rectal
2.3
10.3
102
499
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
3.6
10.3
46
136
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
3.9
10.2
41
111
N05BA01
ATC
diazepam; systemic, rectal
2.6
10.1
79
341
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
2.4
10.0
95
453
R04.2
ICD-10 Finland
Haemoptysis
4.3
10.0
36
88
N02AX02
ATC
tramadol; systemic, rectal
1.9
10.0
216
1454
R03DA04
ATC
theophylline; systemic, rectal
3.4
9.9
48
152
A41.9
ICD-10 Finland
Sepsis, unspecified
4.4
9.9
35
84
Z51.5
ICD-10 Finland
Palliative care
3.6
9.9
44
130
ZXE10
NOMESCO Finland
More than one and less than three hours
1.9
9.8
178
1121
F10.25
ICD-10 Finland
Alcohol dependence continuous use
7.4
9.6
22
31
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
3.9
9.6
39
107
R03AC02
ATC
salbutamol; inhalant
1.9
9.6
235
1646
R06.0
ICD-10 Finland
Dyspnoea
2.1
9.5
121
660
F10.39
ICD-10 Finland
Withdrawal symptoms caused by alcohol UNS
8.3
9.4
20
25
R81
ICPC
Pneumonia
5.2
9.4
28
56
N05AH03
ATC
olanzapine; systemic
3.6
9.3
42
126
Z2221
NOMESCO Finland
Medical doctor
2.0
9.2
135
781
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.8
9.1
229
1604
J47
ICD-10 Finland
Bronchiectasis
8.2
8.9
19
24
TGA30
NOMESCO Finland
Thoracocentesis
14.4
8.7
14
10
WX730
NOMESCO Finland
Conventional respirator
6.4
8.7
22
36
TPH07
NOMESCO Finland
Cathetrisation of artery
2.6
8.7
65
275
Z3231
NOMESCO Finland
Registered nurse
2.0
8.6
138
820
R03AK03
ATC
[D] fenoterol & other drugs for obstructive airway dis; inhalant
3.0
8.6
49
174
XF400
NOMESCO Finland
ECG with 12 standard connections
2.2
8.4
99
518
GAC96
NOMESCO Finland
Other operation on pleura
+∞
8.4
8
*
J44
ICD-10 Finland
Other chronic obstructive pulmonary disease
5.6
8.2
23
43
N03AG01
ATC
valproic acid; systemic, rectal
3.4
8.1
38
118
R56.8
ICD-10 Finland
Other and unspecified convulsions
3.4
8.1
38
118
GAC97
NOMESCO Finland
Other endoscopic operation on pleura
34.0
8.1
10
*
F10.21
ICD-10 Finland
Alcohol dependence currently abstinent, but staying in restrictive environment
7.2
7.8
18
26
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
3.8
7.8
32
89
N06AX11
ATC
mirtazapine; oral
1.9
7.8
141
874
AA1BD
NOMESCO Finland
Extensive CT of head and brain
4.9
7.7
24
51
P01AB01
ATC
metronidazole; oral, rectal
1.8
7.7
162
1052
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.8
7.6
49
189
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.8
7.6
49
189
JN4CD
NOMESCO Finland
Very extensive body CT
3.8
7.6
31
86
J43.9
ICD-10 Finland
Emphysema, unspecified
5.6
7.6
21
39
A02BC02
ATC
pantoprazole; systemic
1.7
7.6
288
2241
GD5AD
NOMESCO Finland
Thorax and upper abdomen combined CT examination of
9.1
7.6
15
17
J13
ICD-10 Finland
Pneumonia due to Streptococcus pneumoniae
10.3
7.6
14
14
N07BB01
ATC
disulfiram; oral
3.2
7.6
38
125
J01FA06
ATC
roxithromycin; oral
1.8
7.5
179
1215
N05AH02
ATC
clozapine; systemic
6.1
7.5
19
32
N06AB04
ATC
citalopram; systemic
2.0
7.4
103
577
JN4AD
NOMESCO Finland
Body CT examination
2.7
7.3
48
188
J15.1
ICD-10 Finland
Pneumonia due to Pseudomonas
+∞
7.3
7
*
WX872
NOMESCO Finland
Intensive care
3.1
7.3
38
129
F29
ICD-10 Finland
Unspecified nonorganic psychosis
4.5
7.2
24
55
GDA20
NOMESCO Finland
Excision of lesion of lung
30.5
7.2
9
*
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.4
7.1
58
256
F10.29
ICD-10 Finland
Addiction caused by alcohol UNS
4.6
7.1
23
52
J44.9
ICD-10 Finland
Chronic obstructive pulmonary disease, unspecified
3.0
7.0
38
132
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
2.8
7.0
45
174
F20.00
ICD-10 Finland
Paranoid schizophrenia continuous
4.8
7.0
22
48
N05CF01
ATC
zopiclone; oral
1.8
7.0
153
1004
H02AB07
ATC
prednisone; oral
2.1
6.9
77
395
R03AC12
ATC
salmeterol; inhalant
3.4
6.9
32
100
J93.1
ICD-10 Finland
Other spontaneous pneumothorax
9.5
6.8
13
14
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.0
6.8
88
479
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
4.1
6.8
25
64
F20.30
ICD-10 Finland
Undifferentiated schizophrenia continuous
7.3
6.8
15
21
C03CA01
ATC
furosemide; systemic
1.8
6.7
151
995
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
4.7
6.7
21
46
X59
ICD-10 Finland
Exposure to unspecified factor
2.0
6.7
91
507
B01AB05
ATC
enoxaparin; parenteral
1.8
6.6
139
895
GAB10
NOMESCO Finland
Antero- or postero-lateral thoracotomy
12.5
6.6
11
9
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
2.7
6.5
42
163
T36
ICD-10 Finland
Poisoning by systemic antibiotics
3.7
6.5
27
77
K51.0
ICD-10 Finland
Ulcerative (chronic) pancolitis
14.6
6.4
10
7
A28
ICPC
Limited function/disability NOS
2.0
6.4
80
430
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.8
6.3
134
868
B18.2
ICD-10 Finland
Chronic viral hepatitis C
9.4
6.3
12
13
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
4.9
6.3
19
40
GAC43
NOMESCO Finland
Total decortication of pleura
+∞
6.3
6
*
GDB20
NOMESCO Finland
Segmental resection of lung
+∞
6.3
6
*
B44.0
ICD-10 Finland
Invasive pulmonary aspergillosis
+∞
6.3
6
*
J18.1
ICD-10 Finland
Lobar pneumonia, unspecified
7.8
6.2
13
17
N05AA02
ATC
levomepromazine; systemic
2.9
6.1
35
126

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
157
159
13.59
145.00
3.2
3.0
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
80
45
20.75
101.15
4.2
4.3
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
106
109
11.90
95.15
1.7
1.3
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
80
61
15.26
86.30
3.1
2.9
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
306
1195
4.67
68.62
8.3
4.5
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
58
48
13.44
59.15
1.4
1.3
e6/l
18675.6
1642.7
1.05
46
31
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
64
64
11.23
57.76
1.3
1.1
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
60
56
11.95
56.68
1.3
1.5
g/l
35.2
30.5
1.46
55
49
(3042936) Bacteria identified in Isolate by Culture
189
633
4.08
49.41
2.6
2.1
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
193
684
3.86
46.08
2.7
1.9
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
48
44
11.89
45.70
1.4
1.3
e6/l
26536.8
44258.1
0.58
33
24
(3012441) Differential panel - Pleural fluid
48
46
11.37
44.36
1.4
1.4
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
74
123
6.83
43.90
1.8
1.7
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
284
1327
3.45
43.51
9.8
6.3
—
—
—
0
0
(3035880) pH of Pleural fluid
37
24
16.49
42.95
1.2
1.1
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
43
37
12.56
42.56
1.5
1.4
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
60
89
7.47
39.44
1.3
1.5
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
179
662
3.57
39.22
6.9
3.9
mmol/l
0.8
0.8
5.00
169
624
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
147
482
3.83
38.56
2.5
1.9
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
148
489
3.81
38.37
2.1
1.4
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
146
487
3.75
37.22
2.5
1.9
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
106
286
4.38
36.27
1.9
1.7
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
43
48
9.66
35.56
1.3
1.7
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
343
1955
3.12
34.79
11.6
6.2
e9/l
0.8
0.6
12.72
308
1682
(3022096) Basophils/100 leukocytes in Blood
327
1820
3.07
34.53
12.0
6.3
%
0.6
0.6
2.42
322
1703
(3006315) Basophils [#/volume] in Blood
343
1961
3.11
34.49
11.7
6.2
e9/l
0.0
0.0
0.94
309
1702
(3006504) Eosinophils/100 leukocytes in Blood
330
1859
3.04
33.85
12.2
6.3
%
2.5
2.9
2.25
325
1735
(3019069) Monocytes/100 leukocytes in Blood
331
1869
3.04
33.78
13.0
6.6
%
8.8
8.9
0.43
326
1757
(3013115) Eosinophils [#/volume] in Blood
349
2029
3.09
33.78
12.8
6.6
e9/l
0.2
0.2
0.32
319
1783
(3014111) Lactate [Moles/volume] in Serum or Plasma
122
384
3.82
33.59
7.2
7.3
mmol/l
1.4
1.4
0.03
116
370
(3019198) Lymphocytes [#/volume] in Blood
345
2002
3.06
33.33
12.2
6.3
e9/l
1.9
1.9
0.02
314
1759
(3003458) Phosphate [Moles/volume] in Serum or Plasma
150
545
3.44
33.15
9.7
6.7
mmol/l
1.0
1.0
0.34
141
508
(3009445) Proteinase 3 Ab [Units/volume] in Serum
76
170
5.05
32.66
1.8
1.4
u/ml
1.7
4.7
—
5
5
(3002030) Lymphocytes/100 leukocytes in Blood
333
1912
2.98
32.49
12.4
6.5
%
23.2
27.3
7.87
327
1787
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
53
85
6.81
32.31
1.9
1.5
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
61
116
5.81
31.36
2.0
1.8
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
60
114
5.81
30.87
2.0
1.8
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
46
67
7.42
30.59
3.9
2.9
—
—
—
0
0
(3000991) Gas panel - Venous blood
113
359
3.73
30.49
9.8
9.5
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
134
479
3.40
30.12
3.9
4.5
u/l
235.5
248.4
0.39
128
451
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
51
85
6.53
29.93
2.1
1.8
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
324
1886
2.84
29.87
12.0
6.3
%
61.6
57.5
6.53
317
1773
(46235355) HIV 1 and 2 tests - Meaningful Use set
150
587
3.17
28.92
2.0
1.8
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
103
320
3.75
28.62
2.3
2.9
g/l
61.7
66.6
5.90
97
294
(3003396) Base excess in Arterial blood by calculation
133
488
3.30
28.52
7.5
7.5
mmol/l
1.4
1.3
0.07
114
392
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
43
64
7.22
28.01
2.0
1.6
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
363
2289
2.84
27.85
19.9
9.8
e9/l
5.4
4.2
11.94
333
2013
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
44
68
6.96
27.70
2.0
1.5
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
132
492
3.24
27.50
7.4
7.4
kpa
5.3
5.1
0.61
125
473
(3027801) Oxygen [Partial pressure] in Arterial blood
132
493
3.23
27.39
7.4
7.4
kpa
11.0
11.8
1.02
124
477
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
45
73
6.64
27.06
2.0
1.6
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
71
175
4.53
26.97
2.6
2.0
ug/l
1.2
1.6
0.20
65
157
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
39
55
7.57
26.63
2.1
1.8
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
24
18
13.92
25.54
4.4
5.1
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
25
21
12.44
24.89
2.5
1.6
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
25
21
12.44
24.89
2.5
1.6
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
109
384
3.31
24.72
5.9
4.8
mmol/l
1.8
1.8
0.01
89
301
(3021447) Carbon dioxide [Partial pressure] in Venous blood
109
388
3.28
24.28
5.9
4.8
kpa
5.8
5.7
0.28
104
375
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
77
224
3.85
23.33
7.6
10.3
mmol/l
24.9
24.7
0.11
71
212
(40758558) Short blood count panel - Blood
197
994
2.56
22.66
14.5
7.5
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
296
1801
2.45
22.57
12.2
6.5
mmol/l
1.2
1.2
4.61
279
1631
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
57
138
4.51
22.05
1.8
1.8
—
151.4
—
0
7
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
26
28
9.71
21.92
2.5
1.5
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
39
68
6.11
21.80
2.3
1.7
—
—
—
0
0
(3019060) Gas panel - Arterial blood
85
280
3.42
21.31
4.8
4.4
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
330
2150
2.41
20.99
10.2
6.9
umol/l
10.0
12.4
2.56
320
2041
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
42
84
5.34
20.32
1.6
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
42
84
5.34
20.32
1.6
1.4
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
27
35
8.07
19.71
2.4
1.5
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
305
1957
2.31
19.58
11.7
7.3
mmol/l
1.2
1.2
3.77
261
1651
(3024561) Albumin [Mass/volume] in Serum or Plasma
283
1765
2.29
19.38
8.6
5.2
g/l
30.4
35.3
20.69
270
1653
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
69
211
3.61
19.33
6.9
5.3
mmol/l
23.6
24.2
0.55
63
194
(3016502) Oxygen saturation in Arterial blood
110
446
2.85
19.21
8.3
7.7
%
95.3
95.4
0.02
105
431
(3021589) Normoblasts [#/volume] in Blood
276
1744
2.21
17.81
20.4
10.1
e9/l
0.0
0.0
0.14
232
1416
(3018418) pH of Serum or Plasma
208
1173
2.27
17.77
8.7
4.5
ph
7.4
7.4
0.11
45
224
(3004789) Transferrin [Mass/volume] in Serum or Plasma
130
602
2.53
17.30
3.6
2.5
g/l
2.1
2.3
3.21
118
564
(3037692) Legionella sp identified in Specimen by Organism specific culture
21
24
9.07
16.88
1.4
1.2
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
30
52
6.05
16.83
1.3
2.0
ug/l
11.7
16.9
2.74
30
52
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
34
67
5.35
16.69
3.2
3.5
%
59.9
59.4
0.05
34
67
(36304419) Bacteria [Presence] in Urine
196
1106
2.22
16.47
3.9
3.3
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
217
1282
2.17
16.19
4.5
3.5
e6/l
28.5
115.7
1.05
174
999
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
123
573
2.49
16.05
3.8
2.6
%
19.1
23.8
3.06
102
491
(3007853) Bacteria identified in Skin by Aerobe culture
115
520
2.55
15.98
2.0
1.7
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
60
190
3.43
15.87
1.6
2.0
g/l
1.8
1.5
1.01
46
164
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
242
1502
2.12
15.79
4.6
3.4
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
29
52
5.84
15.71
1.8
1.6
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
70
247
3.11
15.52
2.2
1.5
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
133
653
2.38
15.41
3.6
2.5
umol/l
9.8
13.1
6.67
121
609
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
51
149
3.68
15.22
3.4
2.5
u/ml
0.3
0.4
1.11
30
77
(3030467) Casts [#/volume] in Urine by Automated count
198
1153
2.14
15.11
3.9
3.4
e6/l
0.5
0.5
0.06
156
865
(1616796) Gas panel - Central venous blood
38
90
4.47
15.05
6.9
2.8
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
38
91
4.42
14.84
3.0
2.1
g/l
123.5
127.2
0.33
24
66
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
93
394
2.65
14.69
2.7
2.5
g/l
0.2
0.2
1.40
82
365
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
180
1020
2.16
14.66
3.0
2.0
mg/l
2.9
3.1
0.38
157
874
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
71
262
2.97
14.54
2.1
1.7
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
264
1746
2.02
13.98
12.3
9.5
inr
1.2
1.3
0.11
75
466
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
15
14
11.00
13.81
1.0
1.3
ug/l
160.9
14.9
—
5
5
(3008536) Aspergillus sp Ab [Presence] in Serum
15
14
11.00
13.81
3.5
1.3
—
—
—
0
0
(3024139) IgG subclass 3 [Mass/volume] in Serum
24
41
6.08
13.64
1.4
1.3
g/l
0.4
0.4
0.20
16
28
(3028192) IgG subclass 2 [Mass/volume] in Serum
24
41
6.08
13.64
1.4
1.3
g/l
2.7
2.6
0.02
16
29
(3027135) IgG subclass 1 [Mass/volume] in Serum
24
41
6.08
13.64
1.4
1.3
g/l
6.7
7.1
0.17
16
29
(3023183) Ammonium ion [Moles/volume] in Plasma
42
117
3.81
13.41
3.5
3.7
umol/l
32.7
35.9
0.35
33
100
(3010421) pH of Blood
39
103
4.01
13.40
8.4
3.9
ph
7.4
7.4
0.36
34
83
(3026782) Osmolality of Urine
150
818
2.16
13.28
3.5
2.9
mosm/kgh2o
523.8
569.6
1.83
134
699
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
62
223
3.02
13.26
8.4
10.2
—
—
—
0
0
(4062490)
24
43
5.80
13.00
1.4
1.3
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
208
1295
2.00
12.79
4.2
2.6
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
77
318
2.66
12.73
5.5
4.6
%
0.1
0.1
0.03
44
100
(3000850) Epithelial cells [#/volume] in Urine
155
870
2.10
12.66
3.9
2.6
e6/l
5.4
4.0
0.89
141
771
(3002179) Metamyelocytes/100 leukocytes in Blood
74
304
2.67
12.35
5.1
4.3
%
0.8
0.4
0.48
36
84
(3018095) Leukocytes [#/volume] in Urine
226
1467
1.94
12.15
5.5
4.1
e6/l
71.0
91.1
0.26
178
1064
(3017181) Myelocytes/100 leukocytes in Blood
79
338
2.57
12.14
5.5
4.5
%
0.9
0.8
0.24
44
113
(3005719) IgG [Mass/volume] in Serum or Plasma
77
327
2.58
12.01
3.8
2.5
g/l
9.9
10.7
0.82
70
299
(3027945) Reticulocytes/100 erythrocytes in Blood
103
501
2.31
11.94
3.4
2.8
%
2.4
1.8
1.45
92
457
(3028026) IgM [Mass/volume] in Serum or Plasma
68
272
2.72
11.94
2.8
1.6
g/l
1.3
1.7
0.66
59
252
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
17
23
7.60
11.90
32.9
21.1
nmol/l
1680.9
1662.1
0.02
17
23
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
21
36
6.03
11.88
1.2
1.1
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
208
1324
1.94
11.77
4.9
3.3
mmol/l
2.3
2.3
2.96
189
1162
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
15
5
30.80
11.70
1.5
1.0
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
330
2445
1.92
11.69
9.6
5.0
mmol/l
7.1
6.8
0.93
321
2306
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
212
1370
1.91
11.37
4.6
3.6
u/l
37.2
35.4
0.20
206
1305
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
91
428
2.36
11.37
2.8
4.7
ug/l
4.9
37.0
1.08
78
364
(3030905) Polymorphonuclear cells [#/volume] in Blood
28
65
4.49
11.36
2.8
3.1
e9/l
5.4
4.7
0.51
28
65
(3008757) Leukocyte morphology finding [Identifier] in Blood
25
54
4.81
11.05
3.7
4.0
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
162
964
1.98
11.05
3.6
2.5
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
148
861
2.00
10.72
2.3
1.8
mg/l
1.7
1.3
0.50
128
676
(3036481) Cortisol [Moles/volume] in Serum or Plasma
81
374
2.38
10.52
2.5
2.1
nmol/l
380.9
363.7
0.17
74
343
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
90
436
2.28
10.46
6.3
3.4
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
197
1284
1.85
10.01
3.6
2.7
u/l
54.5
57.6
0.64
188
1196
(3025159) Blasts/100 leukocytes in Blood
68
298
2.47
9.89
5.9
4.7
%
0.0
0.1
0.66
40
88
(3024980) IgG subclass 4 [Mass/volume] in Serum
27
69
4.07
9.70
1.4
1.7
g/l
0.5
0.9
0.88
18
52
(4015189)
11
11
10.19
9.57
1.2
2.5
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
335
2589
1.79
9.38
6.3
4.4
e6/l
295.5
2607.4
0.79
11
54
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
386
3116
1.87
9.32
15.3
7.9
u/l
86.0
80.0
1.94
377
2921
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
94
487
2.13
9.21
3.4
3.3
umol/l
8.5
9.0
0.09
77
433
(40767503) Oxygen content in Capillary blood by calculation
30
86
3.64
9.20
4.4
2.4
%
14.9
15.7
0.40
16
45
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
67
302
2.39
9.15
6.8
4.0
mmol/l
2.4
2.0
0.25
45
222
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
123
714
1.94
8.78
3.0
3.2
e6/l
1.1
1.0
0.14
63
426
(3003181) Sodium [Moles/volume] in Urine
26
70
3.85
8.72
2.0
1.3
mmol/l
49.6
64.4
1.19
21
62
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
118
686
1.93
8.35
3.3
3.4
e6/l
1.9
1.4
0.44
59
400
(44790048)
23
59
4.03
8.23
1.5
1.9
—
—
—
0
0
(44790049)
23
59
4.03
8.23
1.5
1.9
—
—
—
0
0
(44806118)
23
59
4.03
8.23
1.5
1.9
—
—
—
0
0
(44790047)
23
59
4.03
8.23
1.5
1.9
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
59
264
2.39
8.18
2.2
2.5
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
164
1069
1.77
8.00
3.8
3.1
—
—
—
0
0
(4010399)
63
294
2.30
7.94
1.4
1.4
—
—
—
0
0
(3009343) pH of Capillary blood
67
321
2.24
7.94
7.0
3.8
ph
7.4
7.4
0.06
15
31
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
18
39
4.74
7.93
1.1
1.4
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
29
90
3.35
7.91
5.6
3.4
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
28
85
3.42
7.90
4.4
2.2
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
95
522
2.00
7.89
1.6
1.2
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
21
53
4.08
7.68
1.6
2.0
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
67
326
2.21
7.65
7.0
3.8
kpa
5.0
5.1
0.49
62
303
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
74
375
2.13
7.63
3.5
2.5
u/l
29.0
34.2
0.72
67
320
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
22
58
3.91
7.60
1.5
1.9
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
334
3936
0.59
7.41
4.7
4.5
mmol/l
1.4
1.4
1.40
303
3615
(3024891) Influenza virus A+B Ag [Presence] in Specimen
32
110
3.03
7.41
1.6
1.2
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
130
810
1.80
7.31
4.6
3.9
ng/l
215.3
459.9
0.99
106
659
(3034860) Kappa light chains.free [Mass/volume] in Serum
34
122
2.91
7.31
2.9
4.3
mg/l
159.1
115.8
0.14
27
99
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
34
122
2.91
7.31
2.9
4.3
mg/l
31.9
37.4
0.44
27
99
(3023520) Reticulocytes [#/volume] in Blood
71
360
2.12
7.30
2.4
2.9
e9/l
91.2
69.1
2.37
50
285
(3011412) CD3 cells [#/volume] in Blood
18
42
4.40
7.27
1.6
2.2
e9/l
1.1
0.9
0.53
11
21
(3011288) Drugs identified in Urine by Screen method
26
81
3.32
7.06
10.2
4.4
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
18
43
4.30
7.06
1.7
1.7
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
18
43
4.30
7.06
1.7
1.7
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
18
43
4.30
7.06
1.7
1.7
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
45
193
2.45
6.85
4.2
3.9
mmol/l
25.8
24.7
0.77
45
186
(3019309) Folate [Moles/volume] in Red Blood Cells
123
768
1.78
6.82
2.1
1.7
nmol/l
1234.6
1144.6
0.53
95
589
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
181
1260
1.66
6.76
3.0
2.1
u/l
237.2
300.5
0.36
171
1183
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
14
28
5.11
6.74
1.7
2.6
%
12.8
14.7
—
6
15
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
14
28
5.11
6.74
1.7
2.6
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
27
89
3.14
6.71
1.6
1.5
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
120
752
1.77
6.55
4.6
3.1
mmol/l
2.5
2.4
1.12
107
655
(3037522) Nuclear Ab [Titer] in Serum
87
495
1.91
6.48
1.7
1.3
titre
344.6
441.1
0.42
13
108
(3013707) Erythrocyte sedimentation rate by Westergren method
353
2913
1.63
6.45
6.3
4.1
mm/h
23.4
12.4
14.19
342
2670
(3021960) Folate [Moles/volume] in Serum or Plasma
145
963
1.70
6.42
1.9
1.6
nmol/l
19.2
20.1
0.37
135
816
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
24
76
3.26
6.37
2.2
1.6
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
10
15
6.78
6.33
1.6
1.3
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
26
87
3.09
6.31
7.5
7.2
iu/ml
434.3
178.4
—
7
16
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
35
139
2.62
6.24
1.4
2.4
g/l
3.5
3.1
1.06
27
110
(3020891) Body temperature
38
158
2.51
6.18
8.4
4.7
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
11
19
5.89
6.13
3.6
2.4
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
34
135
2.62
6.07
1.4
2.4
g/l
9.7
10.7
0.40
27
118
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
343
3958
0.62
6.00
4.7
4.5
mmol/l
4.4
4.5
1.74
314
3657
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
244
1869
1.56
5.95
5.7
4.2
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
20
60
3.42
5.77
6.1
3.5
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
12
24
5.09
5.77
1.7
1.7
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
12
24
5.09
5.77
1.7
1.7
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
12
24
5.09
5.77
1.7
1.7
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
12
24
5.09
5.77
1.7
1.7
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
56
285
2.08
5.70
5.4
4.5
ng/l
107.7
86.2
0.62
47
252
(3052851) Hemolysis interference index of Serum or Plasma
31
122
2.64
5.64
5.5
3.0
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
115
742
1.70
5.60
2.2
1.4
g/l
2.8
2.7
0.15
72
460
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
16
42
3.90
5.57
1.1
1.5
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
32
129
2.58
5.56
1.5
1.2
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
35
148
2.46
5.51
1.4
2.3
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
35
148
2.46
5.51
1.4
2.3
g/l
3.9
3.7
0.28
27
107
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
35
148
2.46
5.51
1.4
2.3
g/l
8.3
7.3
2.06
28
112
(1001926) Buprenorphine [Presence] in Urine by Screen method
25
89
2.90
5.48
8.4
2.7
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
31
124
2.59
5.47
1.9
2.7
g/l
0.1
1.1
2.14
26
111
(4035726)
63
342
1.96
5.38
1.7
1.4
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
37
163
2.36
5.34
2.8
1.9
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
74
425
1.86
5.33
2.3
1.7
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
28
108
2.68
5.31
1.6
1.4
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
96
1453
0.59
5.31
4.2
2.8
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
25
92
2.80
5.18
3.4
4.8
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
200
1500
1.53
5.17
2.6
2.3
nmol/l
71.8
76.3
1.31
191
1331
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
35
153
2.38
5.15
2.1
1.7
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
199
1496
1.53
5.07
2.2
2.1
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
10
19
5.34
5.06
1.2
1.2
iu/ml
277.9
145.1
—
10
19
(3014891) Appearance of Pleural fluid
9
9
10.15
5.04
1.4
1.3
—
—
—
0
0
(3022313) Gas panel - Capillary blood
47
236
2.09
4.97
7.8
4.1
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
333
3814
0.66
4.87
4.4
4.1
mmol/l
1.4
1.3
0.42
300
3489
(3028433) Virus identified in Specimen by Culture
11
24
4.66
4.80
1.1
1.2
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
27
108
2.58
4.79
8.1
2.5
—
—
—
0
0
(4306422)
17
52
3.34
4.78
1.2
1.3
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
10
354
0.27
4.68
1.4
1.8
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
29
122
2.46
4.64
1.4
1.5
iu/ml
0.0
0.1
—
6
24
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
15
43
3.56
4.64
1.1
1.1
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
120
1677
0.63
4.62
3.8
4.2
%
18.0
21.0
1.16
46
770
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
10
21
4.83
4.55
1.7
1.7
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
10
21
4.83
4.55
1.7
1.7
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
211
1638
1.48
4.47
5.5
3.9
ng/l
68.2
48.8
0.37
158
1178
(3000764) Benzodiazepines [Presence] in Urine
27
112
2.49
4.46
8.4
2.5
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
360
4038
0.66
4.45
5.1
5.0
mmol/l
2.5
2.7
3.75
328
3709
(40760892) CBC W Ordered Manual Differential panel - Blood
121
835
1.58
4.44
8.8
5.1
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
11
26
4.30
4.37
1.5
1.7
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
209
1626
1.47
4.36
2.5
2.0
pmol/l
87.1
93.6
1.43
127
871
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
10
22
4.61
4.32
1.7
1.7
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
27
114
2.44
4.30
8.0
2.4
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
27
114
2.44
4.30
9.3
2.4
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
78
486
1.71
4.27
2.3
1.6
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
321
2718
1.46
4.24
5.8
4.2
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
16
51
3.20
4.24
1.2
1.3
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
50
274
1.91
4.17
1.9
1.5
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
56
321
1.83
4.07
5.9
3.4
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
8
10
8.10
4.07
9.8
6.8
%
48.2
46.7
—
8
10
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
161
2076
0.68
4.05
4.2
4.8
ug/l
2.1
2.5
0.56
132
1857
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
17
59
2.94
3.93
1.2
1.1
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
15
50
3.06
3.71
9.3
8.5
mmol/l
8.3
7.3
0.39
15
43
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
78
507
1.63
3.64
2.3
2.0
%
2.0
1.6
3.06
66
445
(3001122) Ferritin [Mass/volume] in Serum or Plasma
203
1617
1.41
3.56
4.3
2.7
ug/l
167.5
165.0
0.05
188
1482
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
16
57
2.86
3.55
1.3
1.3
u/ml
1.0
7.1
—
6
17
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
23
99
2.38
3.55
1.9
1.8
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
25
114
2.25
3.40
9.1
2.1
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
38
204
1.93
3.40
8.7
4.8
mmol/l
24.0
25.1
0.73
33
193
(3034426) Prothrombin time (PT)
8
14
5.78
3.35
1.0
1.5
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
334
3732
0.72
3.28
6.8
6.0
mmol/mol
41.5
40.4
0.91
301
3470
(21494755) Public health laboratory ask at order entry panel
15
361
0.40
3.27
1.3
1.4
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
25
116
2.21
3.27
1.7
1.6
—
—
—
0
0
(3017704) Immunofixation for Urine
9
19
4.80
3.25
1.3
1.6
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
11
33
3.38
3.21
1.0
1.2
—
—
—
0
0
(3011648) Oxygen content in Venous blood
11
33
3.38
3.21
2.4
2.8
%
10.8
10.6
0.05
11
33
(4198724)
8
15
5.40
3.20
3.5
1.5
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
7
11
6.43
3.19
1.6
1.4
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
354
3910
0.72
3.15
5.0
4.6
mmol/l
6.2
6.0
0.83
323
3560
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
16
62
2.63
3.07
1.2
1.3
u/ml
2.7
5.2
—
7
26
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
55
342
1.68
3.06
3.8
3.0
ng/l
341.1
199.5
0.79
49
303
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
89
1230
0.67
3.03
2.6
2.9
ug/l
0.6
0.8
1.88
61
777
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
7
12
5.89
3.03
1.3
1.3
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
10
31
3.27
2.78
1.3
1.3
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
5
6
8.40
2.75
1.0
1.3
umol/l
41.2
35.7
—
5
6
(3047181) Lactate [Moles/volume] in Blood
26
132
2.02
2.75
6.7
5.9
mmol/l
1.0
1.4
2.08
21
115
(3000492) Spirometry study
61
401
1.59
2.74
1.7
1.5
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
13
48
2.75
2.73
1.6
1.3
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
13
48
2.75
2.73
7.8
2.8
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
11
37
3.01
2.70
8.5
2.7
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
6
10
6.05
2.70
1.7
1.4
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
6
10
6.05
2.70
1.2
1.1
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
110
821
1.43
2.70
1.8
1.8
pmol/l
473.4
5822839.8
0.50
92
687
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
158
1257
1.37
2.66
4.2
3.2
ng/l
1687.7
1569.2
0.12
150
1079
(4268621)
12
44
2.77
2.56
2.1
2.4
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
5
7
7.20
2.55
1.0
1.1
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
11
39
2.86
2.49
1.2
1.1
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
7
16
4.42
2.48
1.9
1.9
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
10
34
2.98
2.42
1.5
3.3
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
6
12
5.04
2.41
4.0
3.7
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
6
12
5.04
2.41
4.0
3.7
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
9
27
3.37
2.40
1.4
1.1
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
22
407
0.52
2.40
1.4
1.6
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
22
111
2.02
2.39
1.8
1.5
ug/g
169.2
264.1
1.37
13
67
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
11
41
2.72
2.29
2.5
2.0
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
222
1890
1.30
2.28
6.8
5.1
estimate
0.0
0.0
0.00
57
350
(3035350) Ketones [Presence] in Urine by Test strip
223
1901
1.30
2.27
4.8
3.6
estimate
0.0
0.0
0.00
53
348
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
270
2360
1.29
2.26
3.3
2.8
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
11
42
2.65
2.19
1.3
2.8
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
224
1917
1.29
2.19
5.0
3.7
estimate
0.0
0.0
0.50
55
332
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
428
3993
1.37
2.17
43.7
15.3
mg/l
45.1
25.8
17.29
407
3199
(3029937) Albumin [Presence] in Urine by Test strip
129
1024
1.34
2.17
5.6
3.8
estimate
0.0
0.0
0.50
50
337
(3000012) Reticulocyte production index
7
19
3.72
2.15
1.3
2.2
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
7
19
3.72
2.15
1.0
1.1
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
10
234
0.42
2.10
1.1
1.4
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
8
25
3.23
2.10
7.0
3.6
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
14
62
2.29
2.09
5.1
3.2
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
5
10
5.04
2.07
1.0
1.0
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
7
20
3.53
2.06
2.9
4.2
%
97.3
89.8
—
7
20
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
100
771
1.37
2.03
1.4
1.2
u/ml
1.6
1.4
0.16
21
197
(3011397) Hemoglobin [Presence] in Urine by Test strip
112
879
1.35
2.02
4.3
3.7
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
11
44
2.53
2.02
1.3
1.1
—
—
—
0
0
(3002256) Pathology report gross observation
68
491
1.44
2.01
1.2
1.3
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
15
70
2.18
2.00
1.4
1.2
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
27
160
1.72
1.85
3.5
5.0
g/l
0.4
0.3
0.07
13
67
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
17
3.56
1.84
1.0
1.2
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
5
12
4.20
1.82
1.0
1.0
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
5
12
4.20
1.82
1.0
1.2
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
17
87
1.99
1.81
1.8
1.5
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
19
3.18
1.66
1.0
1.2
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
8
31
2.60
1.66
1.9
1.5
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
16
85
1.91
1.56
1.8
1.3
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
5
15
3.35
1.52
1.0
1.4
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
7
27
2.61
1.52
1.0
1.4
u/field
1.3
2.9
—
7
19
(3047007) Chlamydophila sp Ab [Presence] in Serum
11
52
2.14
1.45
1.0
1.2
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
5
16
3.14
1.44
2.0
2.5
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
16
88
1.84
1.43
1.9
1.5
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
37
522
0.69
1.40
3.7
4.5
%
33.7
30.9
0.62
26
357
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
12
60
2.02
1.39
1.0
1.1
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
5
17
2.96
1.36
5.0
12.2
—
—
—
0
0
(3006576) Bicarbonate [Moles/volume] in Blood
5
17
2.96
1.36
3.8
8.5
mmol/l
25.9
26.4
—
5
17
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
16
90
1.80
1.34
1.3
1.3
miu/ml
159.2
272.5
—
5
38
(40761535) Cells panel - Urine sediment
45
328
1.41
1.31
4.1
3.2
—
—
—
0
0
(3044889) 12 lead EKG panel
310
2857
1.20
1.31
5.5
3.9
—
—
—
0
0
(3004451) EKG impression Narrative
6
24
2.52
1.30
1.2
1.3
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
5
18
2.79
1.28
9.2
1.3
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
18
107
1.71
1.27
1.3
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
18
107
1.71
1.27
1.3
1.2
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
8
35
2.30
1.27
6.1
1.2
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
13
70
1.88
1.25
1.5
1.5
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
6
25
2.42
1.24
2.2
3.0
u/ml
28.0
53.9
—
6
25
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
18
108
1.69
1.23
1.2
1.2
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
5
19
2.65
1.22
1.2
1.4
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
5
19
2.65
1.22
1.8
2.3
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
8
38
2.12
1.19
1.9
1.0
—
—
—
0
0
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
5
20
2.51
1.15
2.2
2.4
umol/l
36.0
49.2
—
5
15
(4094501)
5
111
0.45
1.14
1.0
1.1
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
7
30
2.35
1.12
1.0
1.1
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
7
30
2.35
1.12
7.1
2.0
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
8
40
2.01
1.12
1.0
1.2
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
123
1053
1.22
1.11
1.4
1.4
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
28
195
1.46
1.07
1.3
1.3
—
—
—
0
0
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
5
23
2.18
0.98
1.8
1.3
mmol/l
2.6
1.9
—
5
23
(3025018) Bordetella pertussis Ab [Titer] in Serum
5
23
2.18
0.98
1.2
1.4
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
432
4155
1.21
0.96
43.3
17.7
mmol/l
138.5
139.7
10.74
427
4048
(3019150) Specific gravity of Urine by Refractometry
101
861
1.21
0.96
6.5
4.0
kg/l
1.0
1.0
0.02
20
135
(3022217) INR in Platelet poor plasma by Coagulation assay
71
583
1.25
0.96
24.8
24.4
inr
1.6
1.3
—
10
76
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
9
51
1.78
0.95
2.6
2.3
pg
33.1
33.2
—
9
51
(36660697) Celiac disease serology panel - Serum
37
279
1.35
0.93
1.1
1.2
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
52
415
1.28
0.89
2.3
2.4
ug/g
207.2
127.7
1.09
44
342
(3008898) HLA-B27 [Presence]
7
130
0.53
0.89
1.0
1.1
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
91
1058
0.83
0.86
1.7
1.7
mmol/l
1.4
1.4
0.15
76
888
(3019225) pH of Specimen
48
381
1.29
0.86
6.1
4.1
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
18
262
0.68
0.86
2.2
2.5
—
13.1
—
0
16
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
12
72
1.68
0.85
1.0
1.1
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
432
4170
1.19
0.84
43.9
17.8
mmol/l
4.0
4.0
0.08
426
4065
(3048929) Epstein Barr virus Ab [Presence] in Serum
18
122
1.49
0.81
1.3
1.3
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
8
47
1.71
0.81
1.3
1.1
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
0
26
0.00
0.78
0.0
1.1
—
56.4
—
0
21
(3044941) Cell count panel - Synovial fluid
9
53
1.71
0.75
1.7
1.3
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
47
381
1.26
0.73
3.0
2.6
ug/l
10.5
8.8
0.22
40
339
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
5
25
2.01
0.73
1.4
2.4
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
5
25
2.01
0.73
1.4
2.4
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
9
143
0.62
0.70
1.4
1.6
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
162
1475
1.14
0.70
5.5
3.8
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
7
41
1.72
0.70
1.1
1.3
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
17
238
0.70
0.69
1.3
1.3
—
33.9
—
0
18
(3009508) Creatinine [Moles/volume] in Urine
143
1293
1.14
0.69
4.7
3.4
mmol/l
6.5
8.1
4.69
125
1081
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
5
27
1.86
0.68
1.0
1.2
—
7.4
—
0
9
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
23
305
0.74
0.67
2.0
1.4
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
286
2704
1.12
0.67
5.2
3.3
u/l
91.4
53.5
3.57
273
2539
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
7
43
1.64
0.67
2.3
2.6
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
435
4466
0.86
0.67
57.2
22.1
e9/l
8.4
6.8
26.07
426
4338
(3000963) Hemoglobin [Mass/volume] in Blood
435
4465
0.86
0.66
57.3
22.2
g/l
125.1
137.3
35.02
429
4392
(3026361) Erythrocytes [#/volume] in Blood
435
4464
0.86
0.65
56.9
22.1
e12/l
4.2
4.5
28.01
425
4341
(3024731) MCV [Entitic volume]
435
4463
0.86
0.64
56.8
22.0
fl
91.7
91.2
1.51
430
4395
(3035941) MCH [Entitic mass]
435
4463
0.86
0.64
56.6
22.0
pg
30.3
30.4
1.01
430
4394
(3007461) Platelets [#/volume] in Blood
435
4461
0.86
0.62
57.6
22.1
e9/l
283.8
241.2
16.73
426
4346
(3044290) Cell count panel - Cerebral spinal fluid
11
71
1.56
0.62
5.4
1.9
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
8
49
1.64
0.62
1.3
1.1
—
—
—
0
0
(4027681)
0
21
0.00
0.60
0.0
1.2
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
40
483
0.81
0.58
13.1
7.6
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
0
23
0.00
0.58
0.0
1.0
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
49
576
0.84
0.55
1.3
1.3
u/ml
26.6
9.4
0.39
15
223
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
294
2805
1.11
0.55
4.3
3.4
pmol/l
14.9
14.8
0.30
268
2522
(3023410) Appearance of Cerebral spinal fluid
6
38
1.59
0.54
8.2
2.4
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
6
38
1.59
0.54
1.3
1.3
nmol/l
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
6
39
1.54
0.53
1.0
1.0
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
66
576
1.17
0.52
1.3
1.5
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
38
315
1.22
0.52
2.6
3.0
ml/min/173m2
55.6
64.0
0.49
18
136
(3049717) Cytology report of Urine Cyto stain
24
188
1.29
0.52
2.5
3.0
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
9
64
1.41
0.51
1.3
1.6
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
13
92
1.42
0.51
1.7
1.7
mg/l
1421.8
458.6
0.55
13
87
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
13
92
1.42
0.51
1.3
1.3
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
133
1224
1.12
0.49
4.0
3.3
mg/l
713.0
306.7
0.45
102
820
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
7
45
1.56
0.49
1.3
1.0
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
7
46
1.53
0.48
1.4
1.2
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
21
165
1.28
0.45
1.2
1.3
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
15
112
1.35
0.45
1.7
1.9
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
388
3776
1.10
0.43
35.0
13.9
ml/min/173m2
83.8
79.8
2.32
341
3115
(3035320) C reactive protein [Mass/volume] in Body fluid
5
31
1.62
0.43
2.8
1.9
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
13
96
1.36
0.42
1.1
1.1
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
3.7
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
11
79
1.40
0.41
1.0
1.1
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
15
115
1.31
0.39
4.2
2.3
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
19
0.00
0.39
0.0
1.2
—
7.2
—
0
19
(3037556) Urate [Mass/volume] in Serum or Plasma
0
19
0.00
0.39
0.0
1.4
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
13
170
0.76
0.38
1.2
1.0
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
9
70
1.29
0.37
5.6
2.8
u/ml
56.5
5.8
—
9
65
(3042111) Morphology [Interpretation] in Bone marrow Narrative
11
81
1.37
0.36
1.3
1.9
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
6
42
1.43
0.35
1.2
1.3
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
16
200
0.79
0.35
2.8
3.9
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
6
44
1.37
0.34
1.2
1.3
nmol/l
0.8
0.6
—
6
39
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
419
4264
0.92
0.32
20.1
10.8
u/l
25.0
28.1
3.93
410
4121
(3013139) Helicobacter pylori Ag [Presence] in Stool
17
208
0.81
0.31
1.2
1.2
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
29
249
1.17
0.31
7.0
2.9
e6/l
0.8
0.2
0.45
29
241
(3045142) Bone marrow Pathology biopsy report
7
53
1.32
0.31
1.7
1.3
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
13
102
1.28
0.30
2.3
1.6
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
10
130
0.76
0.29
1.0
1.1
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
112
1053
1.08
0.28
6.0
3.3
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
10
76
1.32
0.28
1.7
1.2
u/l
20.8
39.6
—
10
66
(3003740) Influenza virus B Ag [Presence] in Specimen
8
63
1.27
0.28
1.0
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
8
63
1.27
0.28
1.0
1.1
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
13
161
0.80
0.27
1.5
1.7
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
135
1285
1.07
0.25
5.0
4.0
mg/mmol
27.0
9.9
1.03
100
844
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
17
142
1.20
0.25
1.0
1.1
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
12
96
1.26
0.24
1.2
1.3
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
11
137
0.80
0.24
1.6
1.6
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
6
83
0.72
0.24
1.5
1.9
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
5
40
1.25
0.22
1.4
1.3
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
15
178
0.84
0.22
1.3
1.7
nmol/l
43.1
38.8
0.48
15
171
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(44806420)
0
10
0.00
0.21
0.0
2.1
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3022621) pH of Urine by Test strip
24
272
0.88
0.21
5.0
3.1
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(1002224) Polysomnography panel
15
175
0.85
0.19
1.0
1.1
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
12
100
1.20
0.18
1.8
1.4
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
7
59
1.19
0.18
1.9
1.4
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
11
91
1.21
0.17
1.8
1.9
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
7
61
1.15
0.17
1.9
1.4
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
7
61
1.15
0.17
1.9
1.4
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
7
61
1.15
0.17
1.9
1.4
—
—
—
0
0
(40768793) Breast Pathology biopsy report
7
61
1.15
0.17
1.1
1.3
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
7
61
1.15
0.17
1.9
1.4
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
7
62
1.13
0.17
1.9
1.4
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
7
63
1.11
0.17
1.1
1.3
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
5
66
0.76
0.17
1.4
1.3
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
8
70
1.15
0.16
1.4
1.1
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
19
212
0.89
0.14
1.2
1.3
iu/ml
53.8
134.2
—
5
81
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
9
108
0.83
0.13
1.1
1.1
—
10.5
—
0
10
(40761511) CBC panel - Blood by Automated count
421
4173
1.04
0.12
34.5
14.2
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
12
104
1.16
0.12
1.5
1.4
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
58
609
0.95
0.12
1.3
1.3
iu/ml
24.3
36.6
0.88
22
195
(3017446) Testosterone [Moles/volume] in Serum or Plasma
43
452
0.95
0.09
1.8
2.3
nmol/l
13.0
13.6
0.19
32
403
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
28
299
0.93
0.09
1.4
1.4
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
6
57
1.05
0.08
1.3
1.1
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
5
61
0.82
0.08
2.8
3.2
—
—
—
0
0
(3022145) Colonoscopy Study observation
47
452
1.04
0.07
1.6
1.3
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
109
1112
0.98
0.06
4.4
2.9
umol/l
373.6
7627.8
4.58
91
973
(40768443) Skin Pathology biopsy report
16
171
0.93
0.05
1.1
1.3
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
25
261
0.96
0.04
1.5
1.7
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
367
3654
1.01
0.03
41.5
16.2
%
37.4
40.2
7.63
254
2632
(3017732) Neutrophils [#/volume] in Blood
28
271
1.04
0.02
4.0
2.5
e9/l
5.2
4.2
1.05
23
210
(3019832) Treponema pallidum Ab [Presence] in Serum
25
243
1.03
0.01
1.5
1.6
—
—
—
0
0
(3013512) EKG study
121
1202
1.01
0.01
5.4
4.0
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
352
3514
1.01
0.00
5.2
4.2
mu/l
1.8
2.3
0.73
318
3182
(1761482) Bacteria [#/volume] in Urine by Culture
12
117
1.03
0.00
3.3
5.0
—
—
—
0
0
(4034850)
13
127
1.02
0.00
27.7
12.0
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
10
98
1.02
0.00
1.1
1.3
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
19
191
0.99
0.00
2.3
2.4
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
30
300
1.00
0.00
1.6
1.8
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
30.5
—
0
5
(3027300) Silver Birch IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
0
5
0.00
0.00
0.0
2.8
—
0.4
—
0
5
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
5
52
0.96
0.00
2.8
3.5
nmol/l
3.4
6.9
—
5
52
(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
13.1
—
0
6
(3011335) Digoxin [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3025549) Creatine [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3011048) Pyruvate [Moles/volume] in Blood
0
5
0.00
0.00
0.0
1.4
—
77.6
—
0
5
(40765089) Chromosome analysis panel - Blood by G-banded
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
0
7
0.00
0.00
0.0
7.7
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
3.4
—
83.8
—
0
8
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
5
0.00
0.00
0.0
3.0
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
0
7
0.00
0.00
0.0
3.9
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
9
0.00
0.00
0.0
5.1
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
9
0.00
0.00
0.0
9.7
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint J10_ABSCLUNGPNEUMO and mortality.

Females

Parameter HR [95% CI] p-value
J10_ABSCLUNGPNEUMO 4.25 [3.11, 5.8] < 0.001
Birth year 0.992 [0.98, 1.0] 0.069

During the follow-up period (1.1.1998 — 31.12.2019), 385 out of 944 females with J10_ABSCLUNGPNEUMO died.

Males

Parameter HR [95% CI] p-value
J10_ABSCLUNGPNEUMO 4.708 [3.8, 5.83] < 0.001
Birth year 0.988 [0.98, 1.0] 0.018

During the follow-up period (1.1.1998 — 31.12.2019), 890 out of 2011 males with J10_ABSCLUNGPNEUMO died.

Mortality risk

Mortality risk for people of age

years, who have J10_ABSCLUNGPNEUMO.

N-year risk Females Males
1 0.272% 1.001%
5 1.99% 5.415%
10 5.023% 14.01%
15 10.22% 24.788%
20 16.725% 38.003%

Relationships between endpoints

↥

Index endpoint: J10_ABSCLUNGPNEUMO – Abscess of lung

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data